Drawing for BBLAB

USPTO serial 79430856

BBLAB

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
Examiner
TRUSILO, KELLY JEAN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).

Status 686: Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance.

Need help with BBLAB?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Mineral, vitamin, and lactic acid bacteria supplements; mineral supplements; vitamin and mineral supplements; vitamin tablets; vitamin preparations; medicated confectionery; dietary supplements consisting primarily of lactic acid bacteria; nutraceuticals consisting primarily of lactic acid bacteria for use as a dietary supplement; mixed plant extracts tablets, other than essential oils, for pharmaceutical purposes; lactic acid bacteria tablets for medical purposes; oriental medicinal herb extracts for medical purposes; multivitamin preparations; nutraceuticals consisting primarily of probiotics for use as a dietary supplement; oriental medicinal herb extracts pharmaceutical preparations; dietary supplement drink mixes; dietary supplements; anti-oxidants for use as dietary supplements; nutraceuticals consisting primarily of collagen extracted from fish for use as a dietary supplement; nutraceuticals consisting primarily of collagen extracted from fish and shellfish for use as a dietary supplement; nutraceuticals consisting primarily of collagen extracted from milk for use as a dietary supplement; nutraceuticals consisting primarily of collagen extracted from meat for use as a dietary supplement; nutraceuticals consisting primarily of collagen extracted from algae for use as a dietary supplement; meal replacement shakes for medical purposes; dietetic beverages adapted for medical purposes; dietetic foods for medical purposes; meal replacement and dietary supplement drink mixes for medical purposes; meal replacement snacks for medical purposes; dietetic foods adapted for medical purposes; medical teas for slimming purposes; collagen for medical purposes; medical preparations for slimming purposes; slimming capsules; slimming pills; dietary supplements consisting primarily of collagen; nutritional supplements consisting primarily of collagen; nutraceuticals mainly based on oriental medicine for use as a dietary supplement; food supplement consisting primarily of collagen extracted from milk; food supplement consisting primarily of collagen extracted from meat; dietary supplement mainly based on peony; dietary supplement mainly based on dried orange peel; dietary supplement mainly based on cnidium; food supplement consisting primarily of collagen extracted from seaweed; dietary supplement mainly based on safflower leaf; food supplement consisting primarily of vitamin extracted from fruits; food supplement consisting primarily of lactic acid bacteria; food supplement consisting primarily of probiotics lactic acid bacteria extracted from milk products; food supplement mainly based on minerals extracted from vegetable; dietary supplement mainly based on cinnamon; dietary supplement mainly based on angelica root; dietary supplement mainly based on bamboo leaf; dietary supplement mainly based on white atractylis; food supplement consisting primarily of collagen extracted from fish; food supplement consisting primarily of collagen extracted from fish and shellfish; dietary supplement mainly based on corn silkACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 21, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 21, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 15, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 23, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jun 19, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jun 19, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 19, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 8, 2026RFNTREFUSAL PROCESSED BY IB
Dec 22, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 22, 2025RFRRREFUSAL PROCESSED BY MPU
Nov 18, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 17, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 10, 2025DOCKASSIGNED TO EXAMINER
Sep 19, 2025MAFRAPPLICATION FILING RECEIPT MAILED
Sep 19, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 18, 2025LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED
Aug 21, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance